Development of a pharmacist-led drug interaction assessment service for patients with cancer diagnosed with mild to moderate COVID-19 infection requiring outpatient treatment.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41686730

; Alexander Mitchell; Khushminder Dhillon; Mandeep Bains; Sonia Szombathy; Sylvie Labelle

Feb 13, 2026